Product Name:methyl 3-(methoxymethyl)-1H-pyrazole-4-carboxylate

IUPAC Name:methyl 3-(methoxymethyl)-1H-pyrazole-4-carboxylate

Molecular Formula:C7H10N2O3
Catalog Number:CM1045731
Molecular Weight:170.17

Packing Unit Available Stock Price($) Quantity
CM1045731-250mg in stock ƅşƅ
CM1045731-1g in stock ȋƏȤ
CM1045731-5g in stock ƅȋƩœ

For R&D use only.

Inquiry Form


Product Details

CAS NO:318496-66-1
Molecular Formula:C7H10N2O3
Melting Point:-
Smiles Code:COCC1=NNC=C1C(=O)OC
Catalog Number:CM1045731
Molecular Weight:170.17
Boiling Point:

Category Infos

Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Custom pyrazone for customers from all over the world are our main business.

Column Infos

KalVista Pharmaceuticals recently announces Phase 3 KONFIDENT trial of Sebetralstat meets all primary and key secondary endpoints as first oral on-demand therapy for Hereditary Angioedema (HAE). HAE is a rare and potentially life-threatening genetic disease caused by low levels or dysfunction of the C1 inhibitor, associated with uncontrolled plasma kallikrein (PKa) activity and generation of bradykinin (BK).
Sebetralstat is an investigational novel, oral plasma kallikrein inhibitor with a favorable safety profile. It works by targeting the kallikrein–kinin system (KKS), reducing the activity of plasma kallikrein and blocking uncontrolled bradykinin release in HAE attack. The Phase 3 results also show rapid symptom relief in a broad HAE population.